Literature DB >> 19135252

Screening and cloning of multi-drug resistant genes in HL-60/MDR cells.

Gai-Huan Zheng1, Jin-Rong Fu, You-Hua Xu, Xian-Qing Jin, Wen-Li Liu, Jian-Feng Zhou.   

Abstract

OBJECTIVE: To screen and clone multi-drug resistance (MDR) related genes in MDR acute myeloid leukemia cells (HL-60/MDR).
METHODS: HL-60/MDR was established using All-Trans Retinoic Acid. With the HL-60 cells as "tester" and HL60/MDR as "driver", the cDNA library of HL-60/MDR was established by suppression subtractive hybridization. Then 12 of the resulting subtracted cDNA clones were selected for DNA sequencing and homology analysis. The obtained expressed sequence tags (ESTs) were analyzed with the GenBank BLASTN program to identify sequence homologies to known genes.
RESULTS: The HL-60/MDR cells had different multi-drug resistance to six kinds of chemotherapeutic drugs. The 211 positive gene clones in differential cDNA library of HL-60/MDR cells were amplified with PCR and 46 gene clones exhibited differential expression (ratio >3). Twelve gene clones with significant differential expression (ratio >5) were screened out to homology analysis. Of these, 11 matched known genes and the rest 1 showed no significant homology to human or non-human known sequences. It was named as gene clone HA117.
CONCLUSIONS: This effort provides the partial list of genes differential expressed in HL-60/MDR cells and a novel gene HA117 was found to be related to MDR. Identification of these genes contributes to our understanding of MDR development, and potentially provides candidate target genes to overcome MDR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135252     DOI: 10.1016/j.leukres.2008.11.018

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  The novel gene HA117 promotes in vitro and in vivo drug resistance in mouse colon tumor cells.

Authors:  Y X Guo; Y H Xu; G H Zheng; X Q Jin
Journal:  Cancer Gene Ther       Date:  2017-07-21       Impact factor: 5.987

2.  Expression profiles of HA117 and its neighboring gene DPF3 in different colon segments of Hirschsprung's disease.

Authors:  Hang Liu; Yuanyuan Luo; Shuangshuang Li; Shiqi Wang; Ning Wang; Xianqing Jin
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Multidrug resistance strength of the novel multidrug resistance gene HA117: compared with MRP1.

Authors:  Lihua Zhao; Yanhui Sun; Xiaoqing Li; Xianqing Jin; Youhua Xu; Zhenhua Guo; Rui Liang; Xionghui Ding; Tingfu Chen; Siqi Wang
Journal:  Med Oncol       Date:  2010-07-16       Impact factor: 3.064

4.  Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1.

Authors:  Lihua Zhao; Xianqing Jin; Youhua Xu; Yuxia Guo; Rui Liang; Zhenhua Guo; Tingfu Chen; Yanhui Sun; Xionghui Ding
Journal:  J Exp Clin Cancer Res       Date:  2010-07-19

5.  HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6.

Authors:  Shuangshuang Li; Xianqing Jin; Huan Wu; Yi Wang; Xiaoqing Li; Yuxia Guo; Shaoyan Liang
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

6.  HA117 gene increased the multidrug resistance of K562 cells in vitro: an investigation to the function of a novel gene related to drug resistance.

Authors:  Yuxia Guo; Gaihuan Zheng; Xianqing Jin; Youhua Xu; Qing Luo; Xiaomei Liu; Zhenzhen Zhao; Yong Chen
Journal:  J Exp Clin Cancer Res       Date:  2009-05-12

7.  RNA Sequencing Uncovers Molecular Mechanisms Underlying Pathological Complete Response to Chemotherapy in Patients with Operable Breast Cancer.

Authors:  Yongfeng Li; Xiaozhen Liu; Hongchao Tang; Hongjian Yang; Xuli Meng
Journal:  Med Sci Monit       Date:  2017-09-07

8.  Potential association of long noncoding RNA HA117 with tetralogy of Fallot.

Authors:  Quan Wang; Zhili Wang; Chun Wu; Zhengxia Pan; Li Xiang; Hang Liu; Xin Jin; Kerong Tong; Shulei Fan; Xianqing Jin
Journal:  Genes Dis       Date:  2018-03-10

9.  PLCB4 upregulation is associated with unfavorable prognosis in pediatric acute myeloid leukemia.

Authors:  Shiwen Wu; Wei Zhang; Dongqin Shen; Jianle Lu; Li Zhao
Journal:  Oncol Lett       Date:  2019-09-25       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.